In the press

Press releases & News

Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience

Corteva to receive exclusive rights to further develop and commercialize Lavie Bio’s lead product candidates for fruit rot and powdery mildew fungicide biologicals   REHOVOT, ISRAEL – JULY 17, 2023 – Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biologicals company that develops microbiome-based, computational driven bio-stimulant and

Read more

Lavie Bio Receives Canadian Regulatory Approval for ThrivusTM, Expanding Global Reach

The approval by the Canadian Food Inspection Agency triples Thrivus’TM sales territory Rehovot, Israel — May 24, 2023 — Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biological company focusing on improving food quality, sustainability, and agricultural productivity through the introduction of microbiome-based products, today announced it had

Read more

Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Francisco

Rehovot, Israel – March 6, 2023 — Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biological company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, today announced in that its management will be sponsoring and participating at the World Agri-Tech Conference

Read more

Lavie Bio Reports Successful Results for its Bio-Fungicides Programs

Positive results for LAV311 and LAV321 achieved in 2022 in a series of field trials, testing for protection against bunch rot, powdery mildew and blight diseases   Rehovot, Israel – February 28, 2023 — Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biological company focusing on improving food

Read more